News

When Sudden Cardiac Death Happens Without Warning

Almost half of people who experience sudden cardiac death were never diagnosed with cardiovascular disease (CVD) before it was too late, warned investigators. “A substantial number of deaths happen in people we don’t see in the cardiac ward,” said Tobias Skjelbred, MD, a cardiologist at Copenhagen University Hospital and lead author of a new nationwide

Postpartum Intervention Improved PCP Visits in Year After Delivery

A postpartum intervention that prescheduled an annual primary care provider (PCP) appointment for pregnant participants increased their likelihood of visiting their PCP within the year after delivery, according to research presented at the Society of Maternal-Fetal Medicine 2025 Pregnancy Meeting.  Prenatal visits during pregnancy often comprise a period of “high health activation and motivation for

Comprehensive CT scans may help identify atherosclerosis among lung cancer patients

Comprehensive CT scans may help identify atherosclerosis among lung cancer patients

Credit: Pixabay/CC0 Public Domain Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, according to a new study being presented at ACC’s Advancing the Cardiovascular Care of the Oncology Patient course. Comprehensive assessments

Leg muscle may serve as an early warning system for heart failure, study finds

Leg muscle may serve as an early warning system for heart failure, study finds

Representative skeletal muscle T1-weighted spoiled-gradient echo images during different intervals of normoxia-hypercapnia-recovery normoxia gas stimuli in a young male control rat. Images depict the leg muscle pre-contrast injection (A), post-contrast injection after 10 min on normocapnic-normoxia (B), after 10 min on 5% CO2 (C), and after 6 min on recovery normocapnic-normoxia (D). Dotted red line

Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes

Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes

Credit: Pixabay/CC0 Public Domain Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher. Sotagliflozin is a

Home-Based Cardiac Rehab Matches Center-Based Care

Home-Based Cardiac Rehab Matches Center-Based Care

TOPLINE: A home-based cardiac rehabilitation (CR) program has shown similar improvements in fitness, functional capacity, and quality of life as center-based programs in optimally treated patients with heart failure (HF), with both groups demonstrating comparable exercise adherence. This supports home-based rehab as an effective alternative. METHODOLOGY: Researchers conducted a noninferiority trial from 2019 to 2022